Industry investment in dementia research
Investment from industry, such as pharmaceutical and biotech companies, is critical for advancing our understanding of dementia and developing new treatments and therapies for those living with dementia. Investment from industry can help accelerate the pace of research and improve the chances of finding life-changing treatments for dementia.
Office of Health Economics for ARUK (in preparation).
Almost all phase 3 clinical trials in the UK are funded by industry
industry
funding
clinical
trials
phase 3
Office of Health Economics for ARUK (in preparation).